REG - MyHealthChecked PLC - Appointment of Dowgate as Broker

MyhealthcheckedAnnouncement

18/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230118:nRSR0367Na&default-theme=true

RNS Number : 0367N  MyHealthChecked PLC  18 January 2023

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Appointment of Dowgate as Broker

 

MyHealthChecked (AIM: MHC), the consumer home-testing healthcare company,
announces the appointment of Dowgate Capital Limited ("Dowgate") as its Broker
with immediate effect. SPARK Advisory Partners Limited will continue to act as
the Company's Nominated Adviser.

 

For further information contact:

 

 MyHealthChecked PLC                                                    www.myhealthchecked.com (http://www.myhealthchecked.com)
 Penny McCormick, Chief Executive Officer                               via Walbrook

 SPARK Advisory Partners Limited (NOMAD)                                Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Dowgate Capital Limited (Broker)                                       Tel: +44 (0)20 3903 7715
 David Poutney / Nicholas Chambers

 Walbrook PR Limited (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
                                       (mailto:myhealthcheckedplc@walbrookpr.com)
 Paul McManus                          Mob: +44 (0)7980 541 893

 

 

About MyHealthChecked (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com/) )

MyHealthChecked, based in Cardiff, is an AIM-quoted pioneering UK healthcare
company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests
that have been developed following the acquisition of The Genome Store in
November 2020. The tests are available online, and in some cases, for
over-the-counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPUBUBROVUAAAR